Latest:
New or Persistent Acid Reflux May Signal Esophageal Cancer Risk
New or persistent acid reflux, especially after age 50, may mean higher risk for esophageal cancer, particularly in people with other known risk factors.
- About Us
- Advertise / Support
- Editorial Board
- Contact Us
- CancerNetwork.com
- TargetedOnc.com
- OncLive.com
- OncNursingNews.com
- Terms & Conditions
- Privacy
- Do Not Sell My Information
© 2025 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Contributors
Spencer Feldman
Spencer, Assistant Editor of CURE®, has been with MJH Life Sciences since 2024. A graduate of Rowan University with a bachelor's degree in health communication, Spencer manages CURE's Facebook, Instagram and YouTube. He also enjoys spending time with family and friends, hiking, playing guitar and rock climbing.
Latest:
New Guidelines Shift Donor Selection for Patients With Blood Cancer
Advancements in transplant medicine for blood cancers have prompted updates in how doctors choose donors for allogeneic hematopoietic cell transplants.
Amanda Ferraro
Amanda R. Ferraro is a two-time acute myeloid leukemia survivor, a stem cell transplant recipient and a seven-time brain surgery survivor. Amanda is passionate about helping others during their cancer journey, which she does on her website
Latest:
There’s a World of Differences Behind Each Cancer Survivor
Every cancer survivor has a different story and experience, and they should not always be looped into the same category. “Like fingerprints, we all have different characteristics and are individually unique,” writes a survivor.
Erica Finamore
Erica Finamore is an editor and writer from New York City. After 26 months of caregiving, she lost her husband to glioblastoma, a terminal brain cancer, at age 30. She is a brain tumor research advocate and member of the Gray Nation Endurance Team through National Brain Tumor Society.
Latest:
How I Wish You Could Have Seen It All
A wife pens a letter to her husband on the first anniversary of his death from cancer about all the things he’s missed — from the big dates to the boring days, such as just watching TV with their dog.
Dr. Charles E. Geyer
Dr. Charles E. Geyer is a professor of medicine at the University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center and UPMC Magee-Womens Hospital, in Pittsburgh, as well as the chief scientific officer at the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation.
Latest:
Kadcyla Continues to Show Benefits in Early HER2+ Breast Cancer
In HER2-positive early breast cancer, Kadcyla shows sustained improvement in both invasive disease-free survival and overall survival versus Herceptin.
Dr. Andre Henri Goy
Goy serves as physician in chief of Oncology Care Transformation Services at Hackensack Meridian Health. He is also chairman and chief physician officer of John Theurer Cancer Center and leads the lymphoma division at the center’s location within Hackensack University Medical Center.
Latest:
CAR T-Cell Therapy Leads to Remission in a Patients With Lymphoma
Dr. Andre Henri Goy shared how CAR T-cell therapy led a retired pilot with lymphoma into remission, showing the impact of personalized treatment decisions.
Debra Greif
Debra Greif is a retired author, speaker and consultant. Her experience comes from an HR background and dealing with all sorts of “people issues.”
Latest:
Boundaries Are Essential for Happy Holidays During Cancer
The thought of hosting family for a week in the middle of cancer treatment made me anxious, so I set a boundary — and felt much better after the fact.
Dr. Ari Hakimi
Dr. Ari Hakimi is a surgeon and researcher at Memorial Sloan Kettering Cancer Center,
Latest:
Kidney Cancer Research Embraces Biology-Driven Precision Approach
Dr. Ari Hakimi highlighted how tumor profiling and molecular markers are expanding access to precision-based trials for kidney cancer.